BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38270308)

  • 1. m
    Wen Q; Wang S; Hong L; Shen S; He Y; Sheng X; Zhuang X; Chen S; Wang Y; Zhuang H
    Immun Inflamm Dis; 2024 Jan; 12(1):e1150. PubMed ID: 38270308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia.
    Liu Y; Chen Y; Cai M; Hong Y; Wu X; Li S
    Aging (Albany NY); 2023 Sep; 15(18):9858-9876. PubMed ID: 37751592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Liao X; Chen L; Liu J; Hu H; Hou D; You R; Wang X; Huang H
    Epigenetics; 2023 Dec; 18(1):2160134. PubMed ID: 36567510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA m
    Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
    Front Immunol; 2022; 13():905057. PubMed ID: 36389669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia.
    Ding Y; Bajpai AK; Wu F; Lu W; Xu L; Mao J; Li Q; Pan Q; Lu L; Wang X
    Aging (Albany NY); 2024 Jan; 16(3):2340-2361. PubMed ID: 38277218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia.
    Han S; Qi J; Fang K; Wang H; Tang Y; Wu D; Han Y
    Cancer Med; 2022 Mar; 11(5):1413-1426. PubMed ID: 35023630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of N6-Methyladenosine (m
    Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y
    Can J Gastroenterol Hepatol; 2022; 2022():3506518. PubMed ID: 36452120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Li F; Deng Q; Pang X; Huang S; Zhang J; Zhu X; Chen H; Liu X
    Front Oncol; 2021; 11():729887. PubMed ID: 34804923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hub ten gene-based risk score system using RNA m
    Yuan B; Liu W; Huo M; Zhang J; Yang Y; Gao T; Yin X; Yang T; Teng X; Huang W; Yu H
    Breast Cancer; 2022 Jul; 29(4):645-658. PubMed ID: 35174450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
    Xu Z; Chen S; Zhang Y; Liu R; Chen M
    Front Immunol; 2022; 13():869759. PubMed ID: 35603206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer.
    Shen X; Zhong J; He J; Han J; Chen N
    Front Immunol; 2022; 13():978092. PubMed ID: 36105819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of m
    Wang X; Mao Y; Xu H; Chen J; Chen X
    Heliyon; 2023 Sep; 9(9):e19680. PubMed ID: 37809908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
    Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
    Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
    Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
    Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M
    Chen H; Ge XL; Zhang ZY; Liu M; Wu RY; Zhang XF; Xu LP; Cheng HY; Sun XC; Zhu HC
    Transl Lung Cancer Res; 2021 May; 10(5):2172-2192. PubMed ID: 34164268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
    Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
    Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.